Corporate Banner
Satellite Banner
Next Gen Sequencing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

NIH Deposits First Batch of Genomic Data for Alzheimer’s Disease

Published: Monday, December 02, 2013
Last Updated: Monday, December 02, 2013
Bookmark and Share
Researchers can now freely access the first batch of genome sequence data from the Alzheimer’s Disease Sequencing Project (ADSP).

The ADSP is one of the first projects undertaken under an intensified national program of research to prevent or effectively treat Alzheimer’s disease.

The first data release includes data from 410 individuals in 89 families. Researchers deposited completed WGS data on 61 families and have deposited WGS data on parts of the remaining 28 families, which will be completed soon.  WGS determines the order of all 3 billion letters in an individual’s genome.  Researchers can access the sequence data at dbGaP <http://www.ncbi.nlm.nih.gov/gap> or the National Institute on Aging Genetics of Alzheimer’s Disease Data Storage Site (NIAGADS), <https://www.niagads.org/>.

“Providing raw DNA sequence data to a wide range of researchers proves a powerful crowd-sourced way to find genomic changes that put us at increased risk for this devastating disease,” said NIH Director, Francis S. Collins, M.D., Ph.D., who announced the start of the project in February 2012. “The ADSP is designed to identify genetic risks for late-onset of Alzheimer’s disease, but it could also discover versions of genes that protect us. These insights could lead to a new era in prevention and treatment. ”

As many as 5 million Americans 65 and older are estimated to have Alzheimer’s disease, and that number is expected to grow significantly with the aging of the baby boom generation. The National Alzheimer’s Project Act became law in 2011 in recognition of the need to do more to combat the disease. The law called for upgrading research efforts by the public and private sectors, as well as expanding access to and improving clinical and long term care.   One of the first actions taken by NIH under Alzheimer’s Act was the allocation of additional funding in fiscal 2012 for a series of studies, including this genome sequencing effort. Today’s announcement marks the first data release from that project.

Genome sequencing –- determining the order of chemical letters in a cell’s DNA -- is considered a key strategy to identifying new clues to the fundamental cause of Alzheimer’s disease and the development of new diagnostics and treatments. The clues come from differences in the order of DNA letters in Alzheimer’s patients compared to control groups.

To carry out the ADSP, two NIH institutes –- the National Human Genome Research Institute (NHGRI) and the National Institute on Aging (NIA) -- formed a collaboration to manage patient samples and genome sequencing.  NHGRI has devoted $25 million in sequencing capacity at its three flagship centers:  The Genome Institute at the Washington University School of Medicine in St. Louis; the Human Genome Sequencing Center at the Baylor College of Medicine in Houston; and the Eli and Edythe L. Broad Institute of Harvard and MIT, Cambridge, MA.

“NHGRI’s expertise in managing large sequencing initiatives is a hugely important addition to the search for the genetic roots of late onset Alzheimer’s disease,” said NIA Director Richard J. Hodes, MD. “Partnerships between NIH institutes, like this one between NIA and NHGRI, have proved a powerful strategy for focusing research resources on critical public health problems.”

The sequencing centers will produce whole genome sequence of 582 subjects from 111 families in the Family Based Study, a collection of several different groups of patient cohorts.  The cohorts come from the NIH-Late Onset of Alzheimer’s Disease (NIA LOAD); the National Cell Repository for Alzheimer’s Disease (NCRAD); Alzheimer’s Disease Genetics Consortium (ADGC); and the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE), in addition to patient collections provided by several universities.

“Critical to this ambitious genomics project is the well-characterized patient resource developed by the National Institute on Aging,” observed NHGRI Director Eric D. Green, M.D., Ph.D. “Such a partnership between our two institutes will be immensely helpful in establishing how best to use genome sequencing to elucidate the genomic contributions to complex genetic disorders such as Alzheimer's disease.”

In addition to the WGS studies, the three sequencing centers also have begun whole exome sequencing on an additional 11,000 individuals -- 6,000 affected individuals compared to 5,000 controls. Whole exome sequencing determines the order of genomic letters for the approximately 21,000 genes in the human genome, a considerably smaller data set than the 3 billion letters examined in WGS but intensely focused on the protein-producing genes.

The current deposit of genomic data includes phenotypes, such as the Alzheimer’s symptoms of affected individuals, as well as family pedigrees and other demographic information. The rapid release of this community resource follows NIH’s standard rules of data sharing, including requirements for consent and IRB approval. Prepublication release of the raw sequence data also follows The Bermuda Principles and the Ft. Lauderdale Large Scale Biological Sequencing Projects accord of 2003.

“These studies have been designed to have enough statistical power to discover both risk alleles and protective alleles,” said Adam Felsenfeld, Ph.D., director of the NHGRI Genome Sequencing Program. “The analysis of this genomic data is just getting started, and we are looking forward to what we might learn.”

Marilyn Miller, Ph.D., who heads the NIA’s extramural Alzheimer’s disease genetics program, said the large scope of the study is key to success in identifying new genes, and with it, potential targets for more effective interventions. “Because Alzheimer’s is so complex, this broad-based collaborative effort, involving so many participants, will enable us to find potential solutions to tackle the disease.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Genetic Link For Rare Intestinal Cancer
Researchers recommend screening for people with family history.
Thursday, April 16, 2015
Tumor DNA in Blood Reveals Lymphoma Progression
Using an advanced genetic test, researchers were able to detect diffuse large B-cell lymphoma (DLBCL) in blood serum before it could be seen on CT scans.
Tuesday, April 14, 2015
Comprehensive Genomic Study of Sub-Saharan Africans Conducted
New data resource will enhance disease research and genomic diversity studies.
Thursday, December 04, 2014
NIH Exceptional Responders to Cancer Therapy Study Launched
Study to investigate the molecular factors of tumors associated with exceptional treatment responses of cancer patients to drug therapies.
Friday, September 26, 2014
NIH Awards $14.5M for DNA Sequencing Techniques
For the past several years, nanopore research has been an important focus of the program’s grants.
Tuesday, August 05, 2014
NIH Funds $24M into Alzheimer’s Disease Genome Research
Scientists will analyze genome sequence data to identify gene risk, protective factors.
Tuesday, July 08, 2014
Genetic Disorder Causing Strokes, Vascular Inflammation in Children Discovered
NIH researchers have identified gene variants that cause a rare syndrome of sporadic fevers, skin rashes and recurring strokes, beginning early in childhood.
Thursday, February 20, 2014
Speeding Validation of Disease Targets
NIH, industry and non-profits join forces to develop new treatments earlier, beginning with Alzheimer’s, type 2 diabetes, and autoimmune disorders.
Tuesday, February 04, 2014
NCI Launches Trial to Assess the Utility of Genetic Sequencing to Improve Patient Outcomes
Trial could identify patient sub-groups that are likely to benefit from certain treatments.
Saturday, February 01, 2014
NIH Awards Focus on Nanopore Technology For DNA Sequencing
The use of nanopore technology aimed at more accurate and efficient DNA sequencing is the main focus of grants awarded by the NIH.
Monday, September 09, 2013
New Genes for Childhood Epilepsies Discovered
New strategy may find more genes and provide a better understanding of these and other complex neurological disorders.
Monday, August 12, 2013
NIH, Lacks Family Reach Understanding to Share Genomic Data of HeLa Cells
New NIH policy requires researchers to apply for access to the full genome sequence data from HeLa cells.
Thursday, August 08, 2013
NIH Funds New Grants Exploring Use of Genome Sequencing in Patient Care
NIH has awarded four grants for up to four years to multidisciplinary research teams to explore the use of genome sequencing in medical care.
Wednesday, July 24, 2013
NIH Researchers Conduct First Genomic Survey of Human Skin Fungal Diversity
Location on the body surface determines fungal composition with the greatest diversity on feet.
Thursday, May 23, 2013
New NIH/NHGRI Grants to Harness Nanoscale Technologies to Cut DNA Sequencing Costs
Grants of almost $19 million will help to develop technologies to dramatically reduce the cost of DNA sequencing.
Monday, September 17, 2012
Scientific News
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Data Mining DNA For Polycystic Ovary Syndrome Genes
A new Northwestern Medicine genome-wide association study of PCOS – the first of its kind to focus on women of European ancestry – has provided important new insights into the underlying biology of the disorder.
Viral Comparisons
ORNL team applies genomics expertise to analyze, map virus sequence database.
The Tree of Life — More Like A Bush
New species evolve whenever a lineage splits off into several. Because of this, the kinship between species is often described in terms of a ‘tree of life’, where every branch constitutes a species.
Ancient Origins of Deadly Lassa Virus Uncovered
Working as part of an international team in North America and West Africa, a researcher at The Scripps Research Institute (TSRI) has published new findings showing the ancient roots of the deadly Lassa virus, a relative of Ebola virus, and how Lassa virus has changed over time.
Furthering Data Analysis of Next-gen Sequencing to Facilitate Research
Researchers at Cincinnati Children's Hospital Medical Center have developed a user-friendly, integrated platform for analyzing the transcriptomic and epigenomic "big data.
Statistical Technique Helps Researchers Understand Tumor Makeup, Personalize Cancer Treatments
A new statistical method for analyzing next-generation sequencing (NGS) data that helps researchers study the genome of various organisms such as human tumors and could help bring about personalized cancer treatments has been unveiled.
‘Fishing Expedition’ Nets Nearly Tenfold Increase in Number of Sequenced Virus Genomes
Newly developed computational tool finds 12,500 genomes of viruses that infect microbes.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!